X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (99) 99
male (86) 86
chemistry (71) 71
metallurgy (71) 71
female (69) 69
aged (54) 54
electricity (54) 54
physics (53) 53
middle aged (49) 49
human necessities (47) 47
hygiene (45) 45
medical or veterinary science (45) 45
performing operations (45) 45
transporting (45) 45
basic electric elements (39) 39
index medicus (36) 36
urology & nephrology (33) 33
acyclic or carbocyclic compounds (32) 32
organic chemistry (32) 32
specific therapeutic activity of chemical compounds ormedicinal preparations (32) 32
beer (31) 31
biochemistry (31) 31
compositions thereof (31) 31
culture media (31) 31
enzymology (31) 31
microbiology (31) 31
microorganisms or enzymes (31) 31
mutation or genetic engineering (31) 31
propagating, preserving or maintaining microorganisms (31) 31
spirits (31) 31
vinegar (31) 31
wine (31) 31
adult (29) 29
animals (28) 28
measuring (27) 27
testing (27) 27
preparations for medical, dental, or toilet purposes (26) 26
hypertension (25) 25
calculating (21) 21
computing (21) 21
counting (21) 21
rats (21) 21
acyclic, carbocyclic or heterocyclic compounds containingelements other than carbon, hydrogen, halogen, oxygen, nitrogen,sulfur, selenium or tellurium (20) 20
electric digital data processing (20) 20
general tagging of cross-sectional technologies spanning over several sections of the ipc (20) 20
general tagging of new technological developments (20) 20
investigating or analysing materials by determining theirchemical or physical properties (20) 20
japan (20) 20
peripheral vascular disease (20) 20
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (20) 20
technologies or applications for mitigation or adaptation againstclimate change (20) 20
inductances (18) 18
magnets (18) 18
selection of materials for their magnetic properties (18) 18
transformers (18) 18
further section (17) 17
climate change mitigation technologies related totransportation (16) 16
compositions based thereon (16) 16
nephrology (16) 16
organic macromolecular compounds (16) 16
their preparation or chemical working-up (16) 16
blasting (15) 15
heating (15) 15
hemodialysis (15) 15
lighting (15) 15
mechanical engineering (15) 15
medicine & public health (15) 15
surgery (15) 15
weapons (15) 15
diagnosis (14) 14
hypertension - drug therapy (14) 14
identification (14) 14
mechanical metal-working without essentially removingmaterial (14) 14
punching metal (14) 14
aged, 80 and over (13) 13
electric communication technique (13) 13
macromolecular compounds obtained otherwise than by reactionsonly involving unsaturated carbon-to-carbon bonds (13) 13
working or processing of sheet metal or metal tubes, rods orprofiles without essentially removing material (13) 13
basic electronic circuitry (12) 12
cells, cultured (12) 12
electric solid state devices not otherwise provided for (12) 12
heterocyclic compounds (12) 12
semiconductor devices (12) 12
treatment outcome (12) 12
amplifiers (11) 11
erythropoietin (11) 11
hypertension - physiopathology (11) 11
mice (11) 11
renal dialysis (11) 11
urology/andrology (11) 11
antihypertensive agents - therapeutic use (10) 10
devices for introducing media into, or onto, the body (10) 10
devices for producing or ending sleep or stupor (10) 10
devices for transducing body media or for taking media fromthe body (10) 10
drug therapy, combination (10) 10
medicine, general & internal (10) 10
physical or chemical processes or apparatus in general (10) 10
blood pressure (9) 9
chemical or physical processes, e.g. catalysis or colloidchemistry (9) 9
chronic disease (9) 9
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (396) 396
Japanese (65) 65
French (55) 55
German (32) 32
Chinese (11) 11
Korean (4) 4
Portuguese (4) 4
Spanish (2) 2
Danish (1) 1
Greek (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical and Experimental Nephrology, ISSN 1342-1751, 10/2018, Volume 22, Issue 5, pp. 1229 - 1229
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1007/s10157-018-1554-6 
Medicine & Public Health | Nephrology | Urology | HEMOGLOBIN | UROLOGY & NEPHROLOGY | ERYTHROPOIESIS-STIMULATING AGENTS | CHRONIC KIDNEY-DISEASE | PROGRESSION | Anemia | Humans | Kidney | Letter to the Editor
Journal Article
Clinical and Experimental Nephrology, ISSN 1342-1751, 10/2017, Volume 21, Issue 5, pp. 818 - 824
Combination therapy with Daclatasvir (DCV) plus Asunaprevir (ASV) has been proven effective in patients with chronic hepatitis C virus (HCV) infection.... 
Daclatasvir | Nephrology | Medicine & Public Health | Asunaprevir | Hepatitis C infection | Chronic kidney disease | Urology | MORTALITY | VIRUS-INFECTION | RISK | SUSTAINED VIROLOGICAL RESPONSE | CRYOGLOBULINEMIC GLOMERULONEPHRITIS | HEPATOCELLULAR-CARCINOMA | UROLOGY & NEPHROLOGY | HEMODIALYSIS | HCV | EXTRAHEPATIC MANIFESTATIONS | Isoquinolines - adverse effects | Humans | Hepacivirus - genetics | Hepatitis C, Chronic - virology | Male | RNA, Viral - blood | Hepatitis C, Chronic - complications | Renal Insufficiency, Chronic - complications | Viral Load | RNA, Viral - genetics | Time Factors | Aged, 80 and over | Female | Renal Insufficiency, Chronic - diagnosis | Retrospective Studies | Imidazoles - therapeutic use | Drug Therapy, Combination | Kidney - physiopathology | Hepacivirus - drug effects | Glomerular Filtration Rate | Antiviral Agents - therapeutic use | Imidazoles - adverse effects | Japan | Genotype | Treatment Outcome | Hepatitis C, Chronic - diagnosis | Hepatitis C, Chronic - drug therapy | Renal Insufficiency, Chronic - physiopathology | Sulfonamides - therapeutic use | Antiviral Agents - adverse effects | Isoquinolines - therapeutic use | Sulfonamides - adverse effects | Aged | Sustained Virologic Response | Longitudinal Studies | Medical research | Care and treatment | Chronic kidney failure | Analysis | Medicine, Experimental | Hepatitis C | Hepatitis C virus | Health aspects | Hepatitis | Renal function | Epidermal growth factor receptors | Liver | Chronic infection | Interferon | Ribonucleic acid--RNA | Glomerular filtration rate | Kidney transplantation
Journal Article
Therapeutic Apheresis and Dialysis, ISSN 1744-9979, 06/2010, Volume 14, Issue 3, pp. 240 - 275
Journal Article
American Journal of Clinical Nutrition, ISSN 0002-9165, 02/2006, Volume 83, Issue 2, pp. 355 - 361
Background: Although considerable experimental and animal evidence shows that green tea may possess potent activities of neuroprotection, neurorescue, and... 
Mini-mental state examination | Cognitive function | Elderly | Green tea | Japanese | cognitive function | POPULATION | DEMENTIA | PRECURSOR | elderly | ALZHEIMERS-DISEASE | green tea | NUTRITION & DIETETICS | ALCOHOL | COMMUNITY | (-)-EPIGALLOCATECHIN-3-GALLATE | POLYPHENOL | mini-mental state examination | BRAIN | CATECHIN | Health aspects
Journal Article
Nephrology, ISSN 1320-5358, 07/2017, Volume 22, Issue 7, pp. 562 - 565
A fixed‐dose formula that combines Ombitasvir (OBV), Paritaprevir (PTV) and Ritonavir (RTV) has been launched into the field of anti‐HCV therapy in Japan for... 
haemodialysis | hepatitis C virus | ombitasvir | paritaprevir | ritonavir | UROLOGY & NEPHROLOGY | Anilides - therapeutic use | Hepatitis C - drug therapy | Anilides - adverse effects | Humans | Middle Aged | Hepacivirus - genetics | Male | Renal Insufficiency, Chronic - complications | Viral Load | Renal Insufficiency, Chronic - therapy | RNA, Viral - genetics | Ritonavir - adverse effects | Time Factors | Aged, 80 and over | Drug Compounding | Ritonavir - therapeutic use | Female | Hepatitis C - complications | Renal Insufficiency, Chronic - diagnosis | Hepacivirus - drug effects | Liver Cirrhosis - drug therapy | Liver Cirrhosis - diagnosis | Antiviral Agents - therapeutic use | Japan | Genotype | Treatment Outcome | Macrocyclic Compounds - adverse effects | Disease Progression | Macrocyclic Compounds - therapeutic use | Hepatitis C - diagnosis | Liver Cirrhosis - virology | Antiviral Agents - adverse effects | Hepatitis C - virology | Renal Dialysis - adverse effects | Carbamates - adverse effects | Aged | Sustained Virologic Response | Carbamates - therapeutic use | Drug Combinations | Virus diseases | Hepatitis C virus | Health aspects | Protein binding | Hemodialysis | Ritonavir | Liver | Fibrosis | Drowsiness | Glycosylation | Erythema multiforme | Nonstructural proteins | Erythema | Hepatitis C | Genotypes
Journal Article
Journal of Pain and Symptom Management, ISSN 0885-3924, 2015, Volume 49, Issue 5, pp. 853 - 860